top of page

S-adenosyl Methionine & Depression

S-adenosyl methionine (SAMe) for depression in adults.

 

S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.

 

Complementary therapies for clinical depression: an overview of systematic reviews.

 

Nutritional supplements in depressive disorders.

 

Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial.

 

S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.

 

Cognitive remission: a novel objective for the treatment of major depression?

 

Complementary and alternative medicine therapies for perinatal depression.

 

Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression: A Randomized, Double-Blind, Placebo-Controlled Study.

 

Role of betaine in improving the antidepressant effect of S-adenosyl-methionine in patients with mild-to-moderate depression.

 

A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being.

 

S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy.

 

St. John's wort and S-adenosyl methionine as "natural" alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit?

 

The methylation, neurotransmitter, and antioxidant connections between folate and depression.

 

Possible SAMe-induced mania.

 

(1)H, (15)N, (13)C backbone resonance assignments of human soluble catechol O-methyltransferase in complex with S-adenosyl-L-methionine and 3,5-dinitrocatechol.

 

S-adenosyl-L-methionine (SAMe) for smoking abstinence: a randomized clinical trial.

 

Sulfur in human nutrition and applications in medicine.

 

 

Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.

 

Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, S-Adenosylmethionine, and Vitamin D(3) in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression.

 

 

Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats.

 

SAM-e.

 

Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.

 

S-adenosyl-L-methionine co-administration prevents the ethanol-elicited dissociation of hepatic mitochondrial ribosomes in male rats.

 

Temporal study of acetaminophen (APAP) and S-adenosyl-L-methionine (SAMe) effects on subcellular hepatic SAMe levels and methionine adenosyltransferase (MAT) expression and activity.

 

A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.

 

S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review.

 

Popular Herbal and Natural Remedies Used in Psychiatry.

 

A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.

 

Treatment-emergent hypomania possibly associated with over-the-counter supplements.

 

The use of diet and dietary components in the study of factors controlling affect in humans: a review.

 

Complementary and alternative medicine for the treatment of major depressive disorder.

 

Depression in children and adolescents: complementary therapies.

 

Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.

 

S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS.

 

Probiotics Affect One-Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression.

 

Epigenetics in mood disorders.

 

Post-Craniopharyngioma and Cranial Nerve-VI Palsy Update on a MS Patient with Major Depression and Concurrent Neuroimmune Conditions.

 

Superoxide Mediates Depressive Effects Induced by Hydrogen Sulfide in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats.

 

Mood disorders and complementary and alternative medicine: a literature review.

 

Alternative therapies: Part I. Depression, diabetes, obesity.

 

The effect of methylated vitamin B complex on depressive and anxiety symptoms and quality of life in adults with depression.

 

Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions.

 

Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice.

 

Homocysteine, folate, methylation, and monoamine metabolism in depression.

 

Update and critique of natural remedies as antidepressant treatments.

 

Using complementary and alternative medicines for depression.

 

Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties.

 

Are SAMe and 5-HTP safe and effective treatments for depression?

 

Self-help interventions for depressive disorders and depressive symptoms: a systematic review.

 

SAMe targets consumers via the Web.

bottom of page